PREVENT Act of 2022

Bill: 117-s-5114
Sponsor: full_name: Sen. Brown, Sherrod [D-OH]
Introduced: 2022-11-16
Policy area: Government Operations and Politics
Latest action: action_date: 2022-11-16
text: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Summaries:
action_date: 2022-11-16
action_desc: Introduced in Senate
text: <p><b>Prevent Exposure to Narcotics and Toxins Act of 2022 or the PREVENT ACT of </b><b>2022</b></p> <p>This bill requires the U.S. Customs and Border Protection to make containment devices available to its officers, agents, and other personnel and to provide mandatory annual training on the use of containment devices to prevent potential exposure to synthetic opioids.</p>

tv_txt: II 117th CONGRESS 2d Session S. 5114 IN THE SENATE OF THE UNITED STATES November 16, 2022 Mr. Brown (for himself, Mr. Grassley , Mr. Durbin , Mr. Cassidy , Mr. Padilla , Mr. Wicker , Mr. Tester , and Mr. Markey ) introduced the following bill; which was read twice and referred to the Committee on Homeland Security and Governmental Affairs A BILL To amend the Homeland Security Act of 2002 to provide training for Department of Homeland Security personnel regarding the use of containment devices to prevent exposure to potential synthetic opioids, and for other purposes.

1. Short titles This Act may be cited as the Prevent Exposure to Narcotics and Toxins Act of 2022 or the PREVENT Act of 2022 . 2. Training regarding the use of containment devices to prevent potential synthetic opioid exposure (a) Training Section 416(b)(1) of the Homeland Security Act of 2002 ( 6 U.S.C. 216(b)(1) ) is amended by adding at the end the following: (C) How to use containment devices to prevent potential synthetic opioid exposure. . (b) Availability of containment devices Section 416(c) of such Act ( 6 U.S.C. 216(c) ) is amended— (1) in the subsection heading, by inserting , containment devices, after equipment ; and (2) by striking and opioid receptor antagonists, including naloxone and inserting , opioid receptor antagonists, including naloxone, and containment devices . (c) Applicability to other components If the Secretary of Homeland Secretary determines that officers, agents, other personnel, or canines of a component of the Department of Homeland Security other than U.S. Customs and Border Protection are at risk of potential synthetic opioid exposure in the course of their duties, the head of such component shall carry out the responsibilities under section 416 of the Homeland Security Act of 2002 ( 6 U.S.C. 216 ) in the same manner and to the same degree as the Commissioner of U.S. Customs and Border Protection carries out such responsibilities.